drugset / Trial / NCT03746691

Effect of Citalopram on Reflux Episodes in Healthy Volunteers

NCT03746691

Phase 4 Completed 19 enrolled Universitaire Ziekenhuizen KU Leuven
RandomizedCrossoverDouble-blindTreatment

Summary

Citalopram is sometimes used in the treatment for gastro-esophageal reflux disease, however, there are no empirical data to support this. The investigators would like to know if citalopram has an effect on the lower esophageal sphincter pressure, transient lower esophageal sphincter relaxations and reflux episodes. The investigators will investigate this by performing high resolution impedance manometry in healthy volunteers before and after a solid meal. This will be compared to placebo, in a cross-over, randomized, double-blind condition.

Timeline

Start
2017-02-01
Primary completion
2017-07-31
Completion
2017-07-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Citalopram Small molecule 20 mg Intravenous